hair loss from glp-1 GLP1 hope (Tirzepatide) : r/TelogenEffluvium Let's talk hair loss &

73 Currently, a Phase III trial (NCT04822181) investigating SEMAs effect on improving liver fibrosis is ongoing and is expected to conclude on April 25, 2029

and received speakers fees from Boehingher Ingelheim (2021, 2023), Novo Nordisk (20212022), Eli Lilly (2022) and Servier (2021)

The concept of microdosing typically involves starting with doses as low as 0.5 mg to 1.25 mg weekly, which are fractions of the approved 2.5 mg starting dose

They are also mostly aged 25 to 35, so young Millennials

usually mentioned as mild to moderate and temporary as dose escalation is intended, so in most cases, they are resolved after the maintenance dose is reached (153)